SHPMY:OTCMKTS
Shanghai Pharmaceuticals Holdings ADR
US$ 7.08
0.00%
(0.00) Siku 1
1 Okt, 14:50:24 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya SHPMY...
Mtaji wa soko
65.35B
Wastani wa kiasi cha mauzo
116.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
US$ 8.23
Chini kwa wiki 52
US$ 6.41
Beta
0.58
Hisa za wawekezaji
183.81M
Idadi ya wafanyakazi
elfu 49
Mtaji wa soko
65.35B
Wastani wa kiasi cha mauzo
116.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
US$ 8.23
Chini kwa wiki 52
US$ 6.41
Beta
0.58
Hisa za wawekezaji
183.81M
Idadi ya wafanyakazi
elfu 49
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
PR Newswire UK
·
dakika 42 zilizopita
Oracle NetSuite Announces Launch of AI-first QuickStart: NYSE Content Update
Central Oregon Daily
·
dakika 20 zilizopita
Wall St set for lower open as hot inflation data fuels rate-hike bets
GlobeNewswire
·
saa 1 iliyopita
Delixy Holdings Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement
Yahoo Finance
·
saa 1 iliyopita
33-Year History Shows How to Profit Even When a Market Crash Hits
Wasifu
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.
Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list.
Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
Kuhusu Shanghai Pharmaceuticals Holdings ADR
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 48.6
Lilianzishwa18 Jan 1994
Makao makuu-
SektaHealth care provider
Tovutisphchina.com